What We're Reading: Page 119
Industry reads hand-picked by our editors
Jul 01, 2022
Jun 30, 2022
-
The Boston Globe
Bayer AG opens Kendall Square research center focused on cancer
-
Science
Bad news for Paxlovid? Coronavirus can find multiple ways to evade COVID-19 drug
-
The New York Times
Behind the Scenes, McKinsey Guided Companies at the Center of the Opioid Crisis
-
Nature
China’s first mRNA vaccine is close — will that solve its COVID woes?
Jun 29, 2022
-
The Atlantic
This Fall Will Be a Vaccination Reboot
-
The Wall Street Journal
U.S. Supply of Effective Covid Antibody Drug Dwindling
-
The New York Times
As Monkeypox Spreads, U.S. Plans a Vaccination Campaign
-
Endpoints News
Sanofi to cut insulin prices for uninsured from $99 to $35, matching the insulin cap coming through Congress
Jun 28, 2022
Jun 27, 2022
Jun 24, 2022
-
The Wall Street Journal
Merck Pushes Forward With Potential Deal for Seagen
-
Bloomberg
Covid Vaccines Prevented 20 Million Deaths in First Year, Study Finds
-
Reuters
Roche sceptical about investing more in 'guided-missile' ADC cancer drugs
-
Biotech Strategy Blog
An alternate perspective on TIGIT
Jun 23, 2022
-
The Wall Street Journal
Americans With ALS Look to Canada for Promising Drug the U.S. Hasn’t Approved
-
The Boston Globe
DEM BioPharma launches with $70m to take a bite out of cancer
-
The New York Times
F.D.A. Aims to Slash Nicotine Levels in Cigarettes
Previous
